Maytansine
Maytansine is a highly potent microtubule-targeted compound that induces mitotic arrest and kills tumor cells at subnanomolar concentrations[1].
Product Specifications
CAS Number
35846-53-8
Product Name Alternative
NSC 153858
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Microtubule/Tubulin
Type
Natural Products
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/maytansine.html
Purity
99.81
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C[C@]12[C@@]([C@@H]([C@]3([H])C[C@]([C@@H](/C=C/C=C(CC4=CC(N(C(C[C@@H]2OC([C@H](C)N(C)C(C)=O)=O)=O)C)=C(C(OC)=C4)Cl)\C)OC)(NC(O3)=O)O)C)([H])O1
Molecular Formula
C34H46ClN3O10
Molecular Weight
692.20
Precautions
H302, H315, H319, H335
References & Citations
[1]Lopus M, et al. Maytansine and cellular metabolites of antibody-maytansinoid conjugates strongly suppress microtubule dynamics by binding to microtubules. Mol Cancer Ther. 2010;9 (10) :2689-2699.|[2]Remillard S, et al. Antimitotic activity of the potent tumor inhibitor maytansine. Science. 1975;189 (4207) :1002-1005.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740391-100 1x 100 µL
CD81 / TAPA-1 (1.3.3.22), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680149-500 1x 500 µL
CD106 / VCAM1 (1.4C3), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402400-100 1x 100 µL
OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940500-100 1x 100 µL
Progesterone Receptor (PR500), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680775-500 1x 500 µL
Pgp9.5 (UCHL-1) (UCHL1/775), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 